EICHOR
● Completed
Study of PlasmaCap IG in Adults and Children With PIDD
Condition: Primary Immune Deficiency Diseases (PIDD) · Sponsor: Evolve Biologics
About this study
The purpose of this study is to investigate the efficacy, safety, tolerability, and pharmacokinetic profile of the investigational medicinal product (IMP) and to determine, on the basis of historical control data, how it compares with other 10% intravenous immunoglobulin (IGIV) products currently licensed in North America for the treatment of subjects with primary immune deficiency diseases (PIDD).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (12)
| University of California | Los Angeles, California, United States | — |
| IMMUNOe Health & Research Centers | Centennial, Colorado, United States | — |
| University of South Florida | Tampa, Florida, United States | — |
| Allergy Associates of the Palm Beaches, P.A. | West Palm Beach, Florida, United States | — |
| Institute for Asthma and Allergy, PC | Chevy Chase, Maryland, United States | — |
| Optimed Research Ltd. | Little Silver, New Jersey, United States | — |
| Optimed Research LTD | Columbus, Ohio, United States | — |
| Allergy Partners of North Texas | Dallas, Texas, United States | — |
| AARA Research Center | Dallas, Texas, United States | — |
| AAICPA | Irving, Texas, United States | — |
| The Medical College of Wisconsin, Inc. | Milwaukee, Wisconsin, United States | — |
| CHU Ste-Justine | Montreal, Quebec, Canada | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03238079